Gastroenterology Research and Practice / 2019 / Article / Tab 2

Research Article

Quantitative Analysis of HER2 Amplification by Droplet Digital PCR in the Follow-Up of Gastric Cancer Patients Being Treated with Trastuzumab after Surgery

Table 2

Dynamics of plasma HER2 ratios in GC patients by ddPCR during the follow-up period.

Patient IDHER2 ratiosBest responsePFS (months)
0 months2 months4 months6 months8 months10 months12 months

14.592.442.230.890.711.581.04PR12
22.841.551.342.743.56SD6
35.952.141.742.291.843.463.28PR10
46.251.611.121.521.050.781.28PR12
58.192.911.541.062.124.884.64PR10
65.341.182.063.134.026.14PR8
74.792.531.021.542.43.643.88PR10
85.171.521.440.731.031.130.86PR12
92.721.312.293.544.22SD6
103.171.240.891.061.451.061.11PR12
114.441.881.592.043.155.28PR8
123.481.421.891.040.941.221.08SD12

SD: stable disease; PR: partial response; PFS: progress free survival; means time to progressive disease.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.